LOGIN  |  REGISTER
Terns Pharmaceuticals
C4 Therapeutics

Toronto Stock Exchange, LifeSpeak, View From The C-Suite

August 21, 2023 | Last Trade: C$0.37 0.01 -2.63

TORONTO, Aug. 21, 2023 /CNW/ - Mike McKenna, Chief Financial Officer, LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK) shares his Company's story in an interview with TMX Group.

The View From The C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View From The C-Suite visit https://www.tmxmoney.com/en/csuite.html.

About LifeSpeak Inc. (TSX: LSPK)

LifeSpeak is the leading whole-person-wellbeing platform for employers and other organizations that brings together digital education with human support. To learn more, follow LifeSpeak on LinkedIn (http://www.linkedin.com/company/lifespeak-inc), or visit www.LifeSpeak.com.

CNW sponsored announcement. To learn more visit www.newswire.ca.

Recursion

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB